1. Home
  2. |Insights
  3. |Court Issues Final Consent Judgment On United-Sierra Acquisition

Court Issues Final Consent Judgment On United-Sierra Acquisition

Client Alert | 1 min read | 10.16.08

On September 24, 2008, the federal district in Washington, D.C. entered a final consent judgment resolving antitrust allegations concerning UnitedHealth Group's acquisition of Sierra Health Services. Consistent with the judgment's terms, United had already divested its individual Medicare Advantage product line in the Las Vegas, Nevada area shortly after the acquisition closed earlier this year.

The court rejected arguments by the American Medical Association and the Service Employees International Union, submitted under the Tunney Act review process for antitrust consent decrees, that the consent judgment was inadequate and that they should be permitted to present further evidence to the court in additional hearings. The judge ruled that the divestiture requirements of the consent judgment sufficiently addressed the Department of Justice's complaint allegation that the acquisition would harm competition in an alleged Medicare Advantage market. As for the objectors' claims that the acquisition would create undue power for United in the purchase of health care providers' services and in the sale of commercial health insurance products in Las Vegas, the court explained that its review of the consent judgment's adequacy "is limited to the scope of the complaint" and that the Department of Justice had not alleged such harms in its complaint. In oral argument, the court also noted that the Nevada Insurance Commissioner and the Nevada Attorney General also did not challenge the merger on those grounds. Crowell & Moring partner Art Lerner represented United and Sierra in the court's Tunney Act review of the proposed final judgment.

After entry of the judgment in Washington, D.C., the federal district court in Las Vegas, Nevada on October 8, 2008 approved a similar stipulated final judgment resolving allegations by the Nevada Attorney General concerning alleged loss of competition in Medicare Advantage products.

Insights

Client Alert | 3 min read | 11.21.25

A Sign of What’s to Come? Court Dismisses FCA Retaliation Complaint Based on Alleged Discriminatory Use of Federal Funding

On November 7, 2025, in Thornton v. National Academy of Sciences, No. 25-cv-2155, 2025 WL 3123732 (D.D.C. Nov. 7, 2025), the District Court for the District of Columbia dismissed a False Claims Act (FCA) retaliation complaint on the basis that the plaintiff’s allegations that he was fired after blowing the whistle on purported illegally discriminatory use of federal funding was not sufficient to support his FCA claim. This case appears to be one of the first filed, and subsequently dismissed, following Deputy Attorney General Todd Blanche’s announcement of the creation of the Civil Rights Fraud Initiative on May 19, 2025, which “strongly encourages” private individuals to file lawsuits under the FCA relating to purportedly discriminatory and illegal use of federal funding for diversity, equity, and inclusion (DEI) initiatives in violation of Executive Order 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity (Jan. 21, 2025). In this case, the court dismissed the FCA retaliation claim and rejected the argument that an organization could violate the FCA merely by “engaging in discriminatory conduct while conducting a federally funded study.” The analysis in Thornton could be a sign of how forthcoming arguments of retaliation based on reporting allegedly fraudulent DEI activity will be analyzed in the future....